Get started Log in

4272 — Nippon Kayaku Share News

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedMid CapNeutral

Market Cap
¥318bn
Enterprise Value
¥335bn
Revenue
¥242bn

Table: Nippon Kayaku - 9-MTH group results
31/01/2019 07:00
Table: Nippon Kayaku - 6-MTH group results
07/11/2018 07:00
2018 6-month group forecast
30/10/2018 07:30
Table: Nippon Kayaku -2018/19 group forecast
30/10/2018 07:30
Brief: Nippon Kayaku to merge with units
28/08/2018 08:13
Table: Nippon Kayaku -Q1 group results
31/07/2018 08:00
Brief: R&I affirms Nippon Kayaku's rating at "A" and says stable outlook-R&I
05/06/2018 07:17
Table: Nippon Kayaku -2017/18 group results
10/05/2018 08:00
Table: Nippon Kayaku -2017/18 parent results
10/05/2018 08:00
Brief: Chugai Pharmaceutical says waiver of claims in patent infringement lawsuit
11/04/2018 07:47
Brief: Nippon Kayaku initiates phase II clinical trials on NK105 for treatment of breast cancer
21/02/2018 03:32
Table: Nippon Kayaku - 9-MTH group results
31/01/2018 07:00
Brief: Nippon Kayaku unit acquires 100 pct stake in RaySpec
27/12/2017 07:17
Table: Nippon Kayaku - 6-MTH group results
08/11/2017 07:00
Table: Nippon Kayaku -2017/18 group forecast
08/11/2017 07:00
Brief: Chugai Pharmaceutical says lawsuit on patent infringement concerning Herceptin injection and petition for provisional disposition order
08/09/2017 07:26
Table: Nippon Kayaku -Q1 group results
31/07/2017 08:00
Table: Nippon Kayaku -2016/17 parent results
10/05/2017 08:00
Table: Nippon Kayaku -2016/17 group results
10/05/2017 08:00
Table: Nippon Kayaku -9-MTH group results
31/01/2017 07:00